OGXI

OncoGenex Pharmaceuticals Inc. News Headlines

$10.32
*  
0.07
 negative 
0.68%
Get OGXI Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Narrower-than-Expected Loss at OncoGenex - Analyst Blog
3/12/2014 1:34:01 PM - Zacks.com

Pipeline Progress at OncoGenex - Analyst Blog
2/13/2014 5:45:01 PM - Zacks.com

OncoGenex Pharmaceuticals (OGXI) Jumps: Stock Rises 5.8% - Tale of the Tape
2/11/2014 10:25:01 AM - Zacks.com

OncoGenex Provides Update On 3 SYNERGY Trial - Quick Facts
2/11/2014 6:12:00 AM - RTT News

OncoGenex Pharmaceuticals (OGXI) Jumps: Stock Up 6.1% - Tale of the Tape
1/31/2014 10:39:01 AM - Zacks.com

OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan
1/28/2014 9:25:00 AM - Seeking Alpha

Can OncoGenex Pharma (OGXI) Continue to Rise? - Tale of the Tape
1/16/2014 8:03:01 AM - Zacks.com

Good News for OncoGenex on Custirsen - Analyst Blog
11/20/2013 5:06:20 PM - Zacks.com

Sector Update: Biotech Stocks Getting Injection of Buying Interest
11/20/2013 1:44:32 PM - MT Newswires

Lower-than-Expected Loss at OncoGenex - Analyst Blog
11/8/2013 4:05:28 PM - Zacks.com

OncoGenex's Apatorsen in Phase II Study - Analyst Blog
8/28/2013 5:34:55 PM - Zacks.com

Lower-than-Expected Loss at OncoGenex - Analyst Blog
8/13/2013 9:56:22 AM - Zacks.com

OncoGenex OGX-427 in Spruce Study - Analyst Blog
8/7/2013 5:40:01 PM - Zacks.com

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
6/18/2013 11:34:00 AM - Seeking Alpha

Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy?
6/13/2013 4:37:00 PM - Seeking Alpha

Oncogenex to Advance OGX-427 Development - Analyst Blog
5/24/2013 4:27:52 PM - Zacks.com

OncoGenex Loss Lower than Expected - Analyst Blog
5/6/2013 3:26:28 PM - Zacks.com

OncoGenex' OGX-427 Progresses - Analyst Blog
4/12/2013 5:08:04 PM - Zacks.com

OncoGenex's Second Cancer Drug Gaining Investor Attention
3/26/2013 5:51:00 PM - Seeking Alpha

OncoGenex: SYNERGY Trial Is The Major Catalyst In Sight
3/13/2013 7:58:00 AM - Seeking Alpha

OncoGenex Loss Lower than Expected - Analyst Blog
3/11/2013 4:09:37 PM - Zacks.com

OncoGenex' Candidate Progresses - Analyst Blog
2/14/2013 5:50:01 PM - Zacks.com

Isis Pharma Updates on its Pipeline - Analyst Blog
1/11/2013 4:20:01 PM - Zacks.com

Prostate Cancer Market Takes Shape - Part 2: Treatments In Clinical Development
11/29/2012 11:53:00 AM - Seeking Alpha

Trius And OncoGenex Pharmaceuticals: On Their Game
9/13/2012 4:57:00 PM - Seeking Alpha